NCT04816825

Brief Summary

Study title Feasibility and effectiveness of a home monitored rehabilitation intervention using an exergaming approach in COPD patients - a randomized, controlled study. Background and rationale Chronic Obstructive Pulmonary Disease (COPD) is a common chronic disease characterized by persistent airflow limitation caused by significant exposure to noxious particles or gases, particularly cigarette smoking. In Sweden the prevalence of COPD is approximately 8% and the annual estimated cost for society of 9.1 billion SEK. Improving exercise capacity and physical activity levels are important goals in management of patients with COPD and are strong determinants of positive outcomes, including increased quality of life. Major barrier for rehabilitation recommendations is the limited access and adherence to organized center-based exercise programs. Major barriers related to the side of health care organization are budgets and infrastructure and the limitation in time of the programs. From patient's perspective major barriers exist, like distance, and lack of transport to the unit, also in relation to the frequency of the program, which is commonly two times a week. Research question and objectives The primary objective of this study is to investigate whether home-based telemonitored supervised exercise programs using an exergaming approach will be associated to improved physical fitness, measured with the (1-minute sit-to-stand test, 1-MSTST) compared to the ordinary care. The secondary objectives of this study are:

  1. 1.To investigate whether a home-based exergaming program is associated with improved health-related quality of life, exercise capacity, physical activity levels and body composition.
  2. 2.To investigate if the home-based exergaming program is associated with less exacerbations.
  3. 3.To investigate if the home-based exergaming program is associated with improved health care utilization and/or less hospitalization from all causes?

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
92

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 18, 2021

Completed
5 days until next milestone

Study Start

First participant enrolled

March 23, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 25, 2021

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

May 28, 2025

Status Verified

March 1, 2025

Enrollment Period

3.8 years

First QC Date

March 18, 2021

Last Update Submit

May 21, 2025

Conditions

Keywords

COPDTelerehabilitationPulmonary rehabilitationexergaming

Outcome Measures

Primary Outcomes (1)

  • Physical activity

    Change in level of physical activity will be objectively measured with 1-minute sit to stand test

    Baseline and 12 weeks after baseline

Secondary Outcomes (12)

  • Exercise capacity

    Baseline and 12 weeks after baseline

  • Exercise capacity

    Baseline and 12 weeks after baseline

  • Exercise capacity

    Baseline and 12 weeks after baseline

  • Body composition

    Baseline and 12 weeks after baseline

  • Body composition

    Baseline and 12 weeks after baseline

  • +7 more secondary outcomes

Other Outcomes (1)

  • Performance and safety of the device

    Baseline and 12 weeks after baseline

Study Arms (2)

Exergaming

EXPERIMENTAL

The combination of 1) game-console based exercise programs, 2) specifically designed by professional physiotherapists with focus on subjects with a chronic lung disease and 3) weekly distant monitoring with close supervision by a physiotherapist. Individually prescribed exercise program based on tests of patient's physical fitness.

Device: Alkit eSence

Standard rehabilitation

ACTIVE COMPARATOR

Standard rehabilitation at the COPD-Center. This includes recommendations about physical activity according to the general guidelines, however, individualized after each subject's physical fitness level.

Other: Standard rehabilitation

Interventions

Home-based rehabilitation program including computer games and supervised by a physiotherapist.

Exergaming

Standard rehabilitation program at the COPD-Center

Standard rehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Willingness to participate and signed informed consent form
  • Diagnosis of COPD
  • FEV1/FVC (post bronchodilator) \<0.7
  • GOLD severity grade B/D
  • FEV, \< 80% predicted
  • Cognitive ability relevant for the studies as judged by the investigator
  • Living in their own home and able to manage their activities of daily living

You may not qualify if:

  • Rapidly progressing severe disease other than COPD and COPD-related diseases.
  • Influencing the HRQOL during the study time as judged by the investigator, e.g. long-term stay (\>2 weeks) away from home during the study period.
  • Inability to communicate in Swedish.
  • Any condition that may interfere with the possibility for the subject to comply with the study protocol.
  • Already participating in the pulmonary rehabilitation training group 2 times a week.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

COPD-Center

Gothenburg, VGR, 413 45, Sweden

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A randomized clinical controlled study
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2021

First Posted

March 25, 2021

Study Start

March 23, 2021

Primary Completion

December 31, 2024

Study Completion

December 30, 2025

Last Updated

May 28, 2025

Record last verified: 2025-03

Locations